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suggesting that the HS side chain and w a s analysed by treatment with HNOa, chondroitinase ABC or different from glomerular-basement-membrane HSPG. Toquanc h o n d ro itin a s e AC followed by chromatography on Sephadex tify HS we performed an inhibition ELISA using mouse anti-0 -5 0 columns. Heparan sulphate proteoglycan (HSPG) and bodies specific for glomerular-basement-membrane HS glyeosd e r m a t a n sulphate proteoglycan were detected in both the culture aminoglycan side chains. Glomerular visceral epithelial m e d i u m and cell layer of mesangial cells. Culture medium of produced significantly higher levels of HS (between 197.56 g lo m e r u la r visceral epithelial cells contained HSPG and a second p r o te o g ly c a n with the properties of a hybrid molecule containing g/72 h I //g/72 V H S a n d chondroitin sulphate (CS). The cell layer contained P < 0.001). HS production by these cells was inhibited by cyclo-H S P G and CSPG. Detailed analysis of the hybrid molecule heximide, revealing that it was synthesized ck novo. Expression of r e v e a le d th a t it had an apparent molecular mass of 400 kDa.
perlecan mRNA, demonstrated using reverse transcriptase PCR, S X > S /P A G E of hybrid molecules, after treatment with
We h e p a r itin a s e and chondroitinase ABC, revealed a core protein of visceral epithelial cells and mesangial cells have characteristic 8 0 k D a . U sing 1.8% polyacrylamide/0.6 % agarose-gel electropatterns of proteoglycan production. Glomerular visceral epip h o r e s i s , we deduced that the HS and CS were independently thelial cells produced a hybrid proteoglycan containing CS and a t t a c h e d to one core protein. Because glomerular-basement-HS independently attached to its core protein, m e m b r a n e HSPG is thought to be derived from mesangial cells does not bind to monoclonal and polyclonal antibodies known a n d glom erular visceral epithelial cells and this molecule is to react with perlecan. This is the first quantification i n v o l v e d in several kidney diseases, we investigated its synthesis synthesized by both glomerular i n m o r e detail. Anti-(rat glomerular-basement-membrane HSPG) mesangial cells. Differences in m RN A levels between m o n o c l o n a l antibodies (JM403) and anti-(human glomerularwere
INTRODUCTION
glomerulus are thought to play an important role in the patho genesis of a variety of glomerular diseases associated with changes T h e re n a l glomerulus contains two extracellular matrices, the in GBM charge, proteinuria |^] and matrix accumulation. Several g l o m e r u l a r basement membrane (GBM) the mesangial that the ILS glycosamtnoglycan e urinary space < in ,v < . * m a t r i x [1] , which are produced by the glomerular visceral contribute greatly to the negative charge observed on the G e p i t h e l i a l cells, the glomerular endothelial cells and the mesangial [10 12 ]. Kanwar et al. [2] showed leakage of '"^-albumin into the c e l l s . O n e im portant class of constituents of these matrices are t h e proteoglycans, of which chondroitin/dermatan sulphate p r o t e o g l y c a n CSPG /D SPG [2, 3] and heparan sulphate proteoantm ase treatment ol ta n sulphate membrane. We found that antibodies against GBM HS induce phate proteoan acute selective proteinuria in rats [9] , This negative charge g l y c a n (H S P G ) [2, 4, 5] are the major molecules. The quantities results from sulphate and carboxy groups distributed along the a n d p r o p o r tio n s of these constituents may vary between matrices glycosaminoglycan side chains. There have been some reports p r o d u c e d by different cell types [6, 7] . Proteoglycan molecules that question the contribution o f HS to c o n s i s t , in general, of a core protein and glycosaminoglycan side selectivity [13 15] . Podocalyxin [16] and carboxy groups [17] c h a i n s covalently attached to serine or asparagine residues on the could also play a significant role in this respect. However, a c o r e p ro te in [8] . Alterations in the HSPG content of the decreased GBM HS content was found to be accompanied by 760 N. F. van Det and others increased permeability of the glomerular capillary walls, es pecially for anionic molecules such as albumin. It is thought that a change in negatively charged molecules in the GBM results in the albuminuria seen in many types of glomerulopathy including membranous glomerulonephritis [18] , congenital nephrotic syn drome [19] , systemic lupus erythematosus [20] , minimal lesions and diabetic nephropathy [21] [22] [23] [24] [25] . Klein et al. studied the production of HS and CS/DS in both human fetal glomerular visceral epithelial cells [7] and human fetal mesangial cells [26, 27] in vitro, by metabolic labelling with N a286SO,j and [3H]glucosamine. Thomas et al. [28] published results of similar experiments using human adult mesangial cells, and these investigators observed differences between proteoglycans synthesized by fetal and adult cells. These differences mainly consisted of higher proportions of CSPG and HSPG produced by adult mesangial cells as compared with fetal mesangial cells. Also HSPGs synthesized by adult and fetal mesangial cells were not the same. Therefore the first part of this paper is a detailed analysis of proteoglycan production by mesangial cells and glomerular visceral epithelial cells isolated from adult human kidneys. The two cell populations were investigated under the same conditions in order to exclude any experimental differences. These studies were performed using metabolic labelling of the cells with Na235S 0 4 and [8H]glucosamine or [3H]leucine followed by extensive purification steps.
The second part focuses on HSPG, because of the importance of this molecule in several kidney diseases. To our knowledge, no studies have shown quantitative differences in HS synthesis by glomerular visceral epithelial cells and mesangial cells. The earlier reports of HS quantification used metabolic labelling only. However, although this method is sensitive, it can give serious errors in proteoglycan levels if it is the sole method used. Recently, antibodies have been developed that specifically recognize the HS glycosaminoglycan side chains of GBM HSPG, and these antibodies can be used in a sensitive inhibition ELISA [25] to measure HS. Therefore, HS synthesis in both visceral epithelial cells and mesangial cells can be quantified in vitro, and peak fractions obtained by HPLC can be identified. Recent studies have demonstrated that these monoclonal antibodies have high reactivity against the large basement-membrane HSPG, perlecan. Our knowledge of the complete nucleotide sequence of perlecan [29] gives us the opportunity to investigate its expression in different tissues and cell types. Expression of perlecan mRNA by glomerular visceral epithelial cells and mesangial cells was investigated using reverse transcriptase PCR (RT-PCR). 80 //m sieve. This suspension of more than 90 % decapsulated glomeruli was resuspended in DM EM containing 100 units/ml penicillin, 100 /¿g/ml streptomycin and 20% 5FCS. Immediately after the first cellular outgrowth from the glomeruli, glomerular visceral epithelial cells appeared and were detached with PBS/ EDTA (20 mM). These cells were subsequently grown in T75 flasks in DM EM containing 5% &FCS [31] . Outgrowing mesangial cells (generally appearing within 21 days of seeding) were selectively subcultured in 24-well plates as described [30] . The pure populations of cells were washed, treated with trypsin (0.05%) and cultured in T25 and T75 flasks (Greiner, Frickenhausen, Germany). Cells were used between the second and eighth passage. For labelling studies, cells were grown in either T75 flasks or 24-well plates. Culture media for ELISA were collected from cells grown in 12-well tissue culture plates (Costar, Cambridge, MA, U.S.A.).
MATERIALS AND METHODS

Immunofluorescence studies
Both cell types were characterized morphologically by phasecontrast microscopy, and immunofluorescence was performed with different specific antibodies. Cells were grown on sterile glass coverslips in DM EM containing 10 % &FCS. The cells were fixed in acetone for 5 min at 0 °C, air-dried and incubated with primary antibody for 30 min. After extensive washing with PBS, the cells were incubated with appropriate fluorescein isothiocyanate (FITC)-conjugated anti-IgG or IgM for 30 min in the dark. After three washes with PBS, the slides were mounted in l,4-diazobicyclo[2.2.2]octane/glycerol, assessed for fluorescence at 340-380 nm and photographed through a Leitz microscope (Wetzlar, Germany).
The following antisera were used : FITC-phalloidin for actin (Sigma); mouse anti-cytokeratin monoclonal antibody (mAb) (RGE 53) and anti-desmin mAb (Eurodiagnostics, Apeldoorn, The Netherlands); rabbit anti-(human factor VIII) (von Willebrand factor) (Dakopatts); mouse anti-CD 10 mAb (anti-CALLA) (Dakopatts); rabbit anti-(human CR1); anti-5D9 (TN9) specifically recognizing proximal tubular epithelial cells and TN10 specifically recognizing glomerular visceral epithelial cells [32] were a gift from Dr. G. Müller and Dr. M. Nesper (Medizinische Klinik, Tübingen, Germany); rabbit anti-(human collagen types I, III and IV) (Southern Biotechnology Associates, Birmingham, AL, U.S.A.); mouse anti-(human collagen type IV a l and type IV a3) mAbs [33] were a gift from Dr. J. Wieslander (Statens Serum Institute, Copenhagen, Denmark); rabbit anti-(human fibronectin) (Sigma) and anti-laminin mAbs (Calbiochem, La Jolla, CA, U.S.A.); goat anti-(human HSPG) [25, 34] and mouse anti-HS mAbs were produced as described previously [9,251.
Cell culture
Mesangial cells and glomerular visceral epithelial cells were cultured using glomeruli obtained from human kidneys (donors aged between 1.5 and 66 years) which could not be used for transplantation because of anatomical abnormalities. Mech anical dissociation and sequential sieving were performed as described [30, 31] . In brief, renal cortices were minced and passed sequentially through sieves of mesh 400 /¿m, 200 //,m and 150 fim. The sieved material was then exposed to collagenase type-I A (Sigma Chemical Co., St. Louis, MO, U.S.A.) for 20 min at 37 °C. Collagenase was inactivated by the addition of cold medium (DMEM) (Seromed; Dulbecco's modified Biochrom K.G., Berlin, Germany) containing 5 0/ /O heatinactivated fetal calf serum (£FCS) (Hyclone Laboratories, Logan, UT, U.S.A.). The sieved material was collected on a
Metabolic labelling
Confluent human mesangial cells and glomerular visceral epi thelial cells were labelled in leucine-and sulphate-free DMEM supplemented with 2% 5FCS. Metabolic labelling of cells in media supplemented with a dose response of £FCS revealed that a 2% concentration induced a maximal incorporation of the label (results not shown). De novo synthesis of proteoglycans was studied by dual labelling with N a2:,5S 0 4 (lOO/zCi/ml; carrierfree; NEN, Boston, MA, U.S.A.) and [3H]glucosamine (25 /¿Ci/ml) or [3H]leucine (50 /¿Ci/ml) (Amersham Inter national, Amersham, Bucks., U.K.). After 24 h at 37 °C, the radioactive media were removed and the cells were washed three times with cold PBS. The incubation media and three washes were pooled and extensively dialysed against 0.5 M sodium acetate, pH 5.8, at 4 °C with the following protease-inhibitor cocktail: 10 mM EDTA, 5 mM phenylmethanesulphonyl fluoride, 2 mM benzamidine, 50 mM /?-aminohexanoic acid, 0.5 unit/ml aprotinin and 5 mM iodoacetamide. The cells and extracellular matrix were scraped from the plastic dishes with a rubber 'policeman' and extracted for 2 4 h at 4°C by gently shaking in 4 M guanidinium chloride containing 50 mM sodium acetate, pH 5.8, and the protease-inhibitor cocktail, after dialysis as above. Both cell-media and cell-layer fractions were finally dialysed against DEAE buffer (6 M urea, 50 mM Tris, 0.2 % CHAPS and protease-inhibitor cocktail, pH 7.0). The first puri fication step involved a DEAE anion-exchange (5 ml). The fractions eluted in the salt gradient of 0.1-1.0 M NaCl in DEAE buffer were pooled, dialysed and loaded on to a DEAE anion-exchange Bio-Gel TSK DEAE-5PW HPLC column (75 mm x 7.5 mm; Bio-Rad, Richmond, CA, U.S.A.). After ap plication of the sample, the column was extensively washed with DEAE buffer, and bound material was eluted in a linear NaCl gradient (0.1-1.0M). A flow rate of 1 ml/min was used and 1.0 ml fractions were collected. 35S and 3H radioactivity were measured by adding aliquots of the fractions to fluorophore Ultima Gold (Packard) and counting in a Beckman LS-7500 scintillation counter. The conductivity of each fraction was measured using a CDM3 Radiometer conductivity meter (Copenhagen, Denmark) and expressed in milliSiemens (mS). Peak fractions were pooled, dialysed against distilled water at 4 °C, lyophilized and stored at -20 °C until use.
Degradation of proteoglycans
The 3r,S-/3H-labelled glycosaminoglycans were released from the proteoglycan protein core using 0.05 M NaOH in the presence of 1 M NaBH4 for 1 h at 73 °C [35] . The reaction was stopped by dropwise addition of acetic acid to pH 7 followed by Sephadex G-50 column chromatography (bed size 0.9 cm x 25 cm), equi librated with 0.5 M sodium acetate, pH 7.0, containing 0.2% CHAPS, 10 mg/ml BSA and 1 mg/ml heparin. The contents of the column void volume were used for the following analyses: glycosaminoglycan composition and reactivity in ELISAs for HS glycosaminoglycan and HSPG core protein.
Glycosaminoglycan composition
Glycosaminoglycans were analysed by treatment with low-pH (pH 1) HNOa [19, 36, 37] or chondroitinase ABC (2.5 munits) or AC (2.5 munits) (both from Sigma). 35S-/3H-labelled chains that were 10% less sensitive to chondroitinase AC than to chondro itinase ABC were designated DS, whereas those equally sensitive to both enzymes were referred to as CS. After treatment, the reaction mixtures were analysed using a Sephadex G-50 column (0.9 cm x 25 cm) as described above. Some proteoglycans were analysed in more detail using a Hiload 16/60 Superdex HR200 HPLC column (Pharmacia, Uppsala, Sweden) equilibrated with 0.5 M sodium acetate buffer, pH 7.0, containing 0.2 % CHAPS. The column was calibrated with thyroglobulin (669 kDa), apoferritin (443 kDa), ^-amylase (200 kDa), alcohol dehydrogenase (150 kDa), albumin (66 kDa) and carbonic anhydrase (29 kDa).
Electrophoresis in composite gels of 1.8% polyacrylamide/ 0.6% agarose was performed by the method of Carney et al. [38] with minor modifications. The gel was stained with 0.2% Toluidine Blue in 0.1 M acetic acid to visualize HSPG from bovine kidney, dried and exposed to X-ray film (Kodak) at -70 °C. The intensity of the bands on the autoradiogram was determined with a 2202 Ultrascan laser densitometer (LKB, Woerden, The Netherlands).
To determine the apparent molecular mass of some of the
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proteoglycan cores, SDS/PAGE was used. The different proteo glycans were purified as described above and subjected to either chondroitinase ABC and/or heparitinase under the same con ditions. The samples were boiled for 10 min and subjected to SDS/PAGE (5 % gels) under reducing conditions.
ELISA of HS
HS was detected by an inhibition ELISA using mouse antibodies specific for HS glycosaminoglycan side chains as previously described by van den Born et al. [25] . In brief, a constant amount of mAb JM403 was diluted to a concentration giving 80 % of the maximal ELISA signal and preincubated with an equal volume (60 jul) of HS (from bovine kidney; Seikagaku, Tokyo, Japan) at concentrations ranging from 0.2 to 100 /tg/ml for 1 h at 37 °C, followed by 1 h at 4 °C, and tested in the ELISA with HS as the coated antigen. ELISAs were performed over a linear range on the culture media of glomerular visceral epithelial cells and mesangial cells. For these studies cells were grown in 12-well tissue culture plates to confluence and incubated for 24 h in maintenance culture medium (DMEM containing 0.5 % £FCS). They were then cultured for 3 days in DMEM containing 0.5% (5FCS; the used media were collected and cells counted using a Coulter counter (Coulter Electronics, Mijdrecht, The Netherlands). To study whether HS was synthesized de novo, replicate wells of cells were grown in 12-well tissue culture plates. The cells were washed three times with PBS and maintained for 24 h in DMEM containing 0.5 % &FCS. Subsequently they were cultured in either maintenance medium alone or medium con taining 1 /¿g/ml cycloheximide. At timed intervals culture media were removed and HS was measured using the above ELISA. Cells were counted as above. Simultaneously, cells were grown with or without cycloheximide, washed and then cultured for additional periods in normal media, and HS in the media was determined.
Semiquantitative measurement of perlecan mRNA
Total RNA was isolated from glomerular visceral epithelial ce and mesangial cells grown in T25 flasks in medium as describes by Chomczynski and Sacchi [39] . For PCR, oligonucleotide primers specific for human perlecan [40] 
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Statistical analysis
Data for control and experimental groups are expressed as means ± S.D. Statistical analysis was performed using Student's t test for unpaired samples, and a P value of ^ 0.05 was used to determine significance. 
RESULTS
Characterization of human mesangial cells and glomerular visceral epithelial cells
Mesangial cells formed elongated cells in multilayers, whereas glomerular visceral epithelial cells formed a confluent monolayer of polygonal cells (Figures la and lb respectively) . The cells were incubated with specific antisera ( Table 1) .
Incorporation of radioactively labelled sulphate and glucosamine into macromolecules
Glomerular visceral epithelial cells and mesangial cells were metabolically labelled for 24 h with Na235S 0 4 and [3H]glucosamine in sulphate-free medium supplemented with 2 % £FCS. After 24 .h, the culture media were harvested. They contained 53.2-70.0% of the total incorporated radioactivity. The guanidinium chloride fraction containing both the intra cellular components and extracellular matrix represented 30.0-46.7% of the total incorporated radioactivity. Less than 1 % was left on the culture dishes after extraction. Both the cell supernatant and cell layer were purified twice by DEAE anionexchange chromatography. The second purification step involved an HPLC column. For both cell types this resulted in the separation of two more or less distinct peaks (I and II) which were pooled as indicated in Figure 2 . A portion of the total labelled macromolecules retained on the HPLC column were eluted at the beginning of the salt gradient (fractions 1-40). Glycosaminoglycans were not detected in these fractions.
Degradation of proteoglycans
The culture medium of mesangial cells contained almost equal amounts of HSPGs (peak 150.8 + 2.8 % of the total proteoglycan production; n -3) and DSPGs (peak II 49.2±2.8% of total; n = 3) ( Table 2 A). The cell layer of mesangial cells also contained 
Table 2 Composition of proteoglycans produced by mesangial cells (A) and glomerular visceral epithelial cells (B) In culture
Numbers are percentage sensitivity; ELISA data are given as positive (inhibition > 30%) or negative (Inhibition < 30%).
Culture medium Cell layer Figure 3) , revealing either the presence of a mixture of CSPG and HSPG or a hybrid molecule with the different glycosaminoglycan side chains at tached to one core protein. However, no positivity was observed in either the HS ELISA or the ELISA using polyclonal antibodies directed against the HSPG core protein, indicating that HS in this peak is different from that in peak I of the culture medium of these cells and is possibly not perlecan, as these antibodies have been shown to recognize this basement-membrane HSPG. The cell layer of these cells contained HS (79.4 ±0.2% of total; = 3). All calculations were based on [3H]glucosamine radioactivity. 
Analysis of the CS-and HS-bearing proteoglycans
To investigate whether the contents of peak II of the culture medium of glomerular visceral epithelial cells contains a mixture of, or a hybrid molecule derived from, HSPG and CSPG, we metabolically labelled these cells with 50 /iCi/ml [®H]leucine and 100 /iCi/ml N a2a8S 0 4 for 24 h in sulphate-and leucine-free DMEM containing 2 % iFCS. The different proteoglycans were isolated as described in the Materials and methods section. Peak II (Figure 2c ) was loaded on to a Superdex HR200 size-exclusion column equilibrated in 0.5 M sodium acetate buffer, pH 7,0, containing 0.2 % CHAPS. A similar method was used to analyse a mixture of peak I and II from mesangial cells (Figure 2a) , the latter serving as controls. Figure 4 shows the profiles. Peak II isolated from the culture medium of glomerular visceral epithelial 764 N. F. van Det and others cells consists of one main peak and one small shoulder after Superdex HR200 separation (Figure 4a ), whereas a mixture of peaks I and II isolated from mesangial-cell culture medium eluted as two peaks (Figure 4d ). When the control mixture (peaks I and II of mesangial-cell culture medium) was treated with chondroitinase ABC (which cleaves both DS and CS chains), a small unsulphated [*H]leucine peak appeared at 0.142 ( Figure  4e) , which represents the CSPG core protein without the attached CS side chains. Treatment of the control mixture of mesangialcell culture medium with H N 0 2 resulted in another small unsulphated [3H]leucine peak with a Kav of 0.127 (Figure 4f ), representing the HSPG core protein. However, treatment of peak II from glomerular-visceral-epithelial-cell culture medium (HS/CS) with either H N 0 2 or chondroitinase ABC produced no small unsulphated peaks. These findings suggest the presence of HS and CS in a hybrid molecule. Unfortunately no unsulphated peak was observed after treatment with both HNOa and chon droitinase ABC, but there was loss of radioactivity near the void volume. This peak is probably diluted in the large bed volume of the column.
SDS/PAGE was used to determine the size of the hybrid core protein ( Figure 5 ). For this purpose peak II of glomerular visceral epithelial cells was treated with chondroitinase ABC, heparitinase or both. After silver staining, several irrelevant protein bands appeared within the heparitinase control. The arrow identifies the sharp band observed between 97 and 66 kDa, which appeared after both enzyme treatments of peak II ( Figure  5, lane 3) . This band represents the core protein of the hybrid molecule. Note that it is specific, as it is not seen in lanes 5 and 6 in which the enzymes alone were analysed. No such 80 kDa band was generated when peak II was treated with either of the enzymes alone (lanes 2 and 4). As a control, peak I from glomerular-visceral-epithelial-cell culture medium was run both before and after heparitinase digestion. HSPG core protein migrated with a molecular mass of about 380 kDa (estimated by extrapolation; lane 7). To analyse whether the different types of glycosaminoglycan were independently attached to the core protein or attached via each other, 1.8% polyacrylamide/0.6 % agarose-gel electrophoresis was performed. Large quantities of peaks I and II of the glomerular-visceral-epithelial-cell culture medium were purified (for purity see Figure 5 ) as described in the Materials and methods section. These peaks were labelled with 125I in the presence of Iodobeads at room temperature for 20 min. The protein-bound iodine was separated from free iodine on a Sephadex G-50 column. When 126I-labelled peak II was treated with heparitinase, there was a reduction (46. Figure 6 , lane 3). When peak II was treated with chondroitinase ABC a reduction in intensity (73.7 %) of the original band was observed (lane 5). However, the band com pletely disappeared only when peak II was treated with both enzymes (lane 6). That the hybrid proteoglycan did not show a large change in migration in polyacrylamide/agarose after chondroitinase ABC treatment has been shown by Klein et al. [7] . It can be explained by the fact that only a few CS chains may have been present in the molecule (see also Figure 4 ; sensitivity to chondroitinase ABC was 35% ). The different glycosaminoglycan chains probably account for only a small proportion of the molecular mass of the intact proteoglycan (compare Figure 3a with Figure 3b) . A relatively small CS chain may, however, account for a substantial proportion of the negative change. This may explain the large decrease in intensity on the autoradiogram after chondroitinase treatment ( Figure 6 ). This confirms that the different glycosaminoglycans (CS and HS) are independently attached to one core protein, as disappearance of the band would have occurred after only one of the enzyme treatments if the different glycosaminoglycans were attached to each other. c;
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Production of HS
Glomerular visceral epithelial cells and mesangial cells were cultured in 12-well plates to confluence in medium after which they were starved for 24 h in DMEM containing 0.5 % tfFCS. The cells were then washed three times with PBS, and fresh medium was added to the wells. Three wells were treated with trypsin and the cells were counted in a Coulter counter to deter mine the number present at the beginning of the assay. After 3 and 6 days, the culture media (1 ml/well) were harvested and HS production was assessed. The results are means ± S.D. from three different cultures. Cell numbers did not change significantly during the experiment. Mesangial cells produced between 29.8 and 45.5 /¿g/72 h per 10B cells (Table 3) (Figure 7) . The effects of cycloheximide were completely reversible 72 h after treatment, suggesting that the synthesis was de novo and that no cytotoxicity had occurred.
Expression of perlecan
Expression o f perlecan in the two types of glomerular cell was analysed by the RT-PCR method. Cells were grown in T25 flasks in medium for 3 days, and total RNA was isolated. We used a gene-specific primer (nested cDNA primer) for cDNA synthesis which lies adjacent to, and downstream of, a pair of PCR primers used in the second step for PCR amplification. The [41, 42] . Both cell types show amplification of amide/0.6 % agarose-gel electrophoresis was performed, and domain I of the human perlecan sequence (Figure 8) . The from the results it was deduced that HS and CS were in-GAPDH controls of the two cell types were more or less dependency attached to the core protein of the hybrid molecule, comparable. The intensity of the perlecan PCR fragment from Rapraeger et al. [43] have previously reported another hybrid mesangial cells is greater than that from glomerular visceral proteoglycan, syndecan-1, bearing both HS and CS produced by epithelial cells, suggesting higher steady-state perlecan mRNA mouse mammary epithelial cells and Kato et al. [44] have also levels in mesangial cells.
DISCUSSION
found a hybrid proteoglycan with the same core protein bearing HS and CS side chains. This latter group suggested that the CS content of a hybrid proteoglycan may be involved in modifying the potential binding activity of HS to other basement-membrane The two cell types used in this study were fully characterized on components. This feature may be important, as binding of HS to the basis of their morphology and immunofluorescence with other basement-membrane components may be involved in different specific antibodies. The results confirm and extend several kidney diseases. The occurrence of a hybrid proteoglycan earlier reports [1, 30, 31] . As the isolated glomerular preparation has also been described in more recent studies. Danielson et al. was decapsulated and virtually free of fragments of Bowman's [45] isolated a hybrid proteoglycan synthesized by EHS-derived capsule and tubules when studied by phase-contrast microscopy, cells containing two to three HS chains and one CS chain a visceral rather than a parietal origin of the epithelial cells seems attached to a large 400 kDa protein core. Isemura et al. [46] likely. Positive staining of the cultured glomerular visceral purified from human placenta a hybrid proteoglycan with a epithelial cells with TN10 confirms that these cells were visceral 800 kDa core protein and both HS and DS side chains. It is clear in origin [32] . / that the various hybrid proteoglycans described vary in molecular size and glycosaminoglycan content. Also differences in the size labelled macromolecules synthesized by adult mesangial cells of the core protein were found. However, both the results of and glomerular visceral epithelial cells are proteoglycans, but Klein et al. [7] and our studies suggest the production of a large they are qualitatively and quantitatively different. Mesangial hybrid proteoglycan containing both HS and CS side chains cells were found to produce both HSPG and DSPG, which were attached to a small 80 kDa core protein. isolated from the culture medium and cell layer. Glomerular
Up until now all studies on proteoglycan production by visceral epithelial cells produced HSPG and CSPG (almost glomerular visceral epithelial cells and mesangial cells have been equally sensitive to chondroitinase ABC and AC [7] ). However, performed by metabolically labelling these cells with Na235S04 and [3H]glucosamine or [3H]leucine. One of the advantages of 3H-isolation of proteoglycans from the culture medium suggests the presence of a hybrid molecule bearing HS and CS (peak II, Figure 2c ), as digestion of this peak demonstrated sensitivity to labelled glycosaminoglycan or 3H-labelled core protein can be this method is that the ratio between Na235S04 and studied in detail. Furthermore, this method allows the possibility of studying all types of proteoglycan produced by these cells, and determination of their molecular masses. However, quantification of metabolic labelling can lead to serious errors if it is the sole method used. As far as we know, it has not been possible to column. This resulted in a single peak (Kav 0.047). Treatment determine accurately the amount of HSPG produced. Using HNOa (50.1 %), chondroitinase ABC (35.4 %) and chondroitinase AC (34.3 %) ( Figure 3 and Table 2 ). For more detailed analysis, metabolic labelling with Na235S04 and [3H]leucine was per formed. The isolated peak II was fractionated using molecularsieve chromatography on a Hiload 16/60 newly developed antibodies specific for GBM HS side chains in a sensitive inhibition ELISA, the production of HSPG by both with either chondroitinase ABC or HNOa resulted in no large shift in a part of the 3H-labelled peak, suggesting that only one core protein was present (Figure 4) . A shift should have been glomerular visceral epithelial cells and mesangial cells can be observed as the expected molecular mass of the hybrid core measured more accurately. This will enable the study of factors protein is only 80 kDa [7] . The Kav of the fraction treated with that affect HSPG production. Results of such studies can then be 768
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of N aa35SO,/[3H]glucosamine or compared with those [3H]leucine incorporation into macromolecules. This might allow differentiation between release of stored HSPG and de novo production and also comparison between the production of perlecan and non-perlecan HSPG. Recent studies performed in our laboratory show high reactivity of the mAbs used in this ELISA against the large basement-membrane HSPG (perlecan) (results not shown). RT-PCR demonstrates expression of perlecan in both cell types. As the method used theoretically cannot precisely reflect the steady-state level of perlecan mRNA, Northern-blot analysis was performed and revealed that glom erular visceral epithelial cells express mRNA at a lower level than mesangial cells (results not shown).
In summary, this study describes the production of DSPG and HSPG as well as expression of perlecan mRNA in mesangial cells. Glomerular visceral epithelial cells produce CSPG and HSPG and a hybrid molecule bearing HS and CS chains independently attached to its core protein. These cells also express perlecan. The majority of HSPG produced by the two cell types reacts with mAbs known to bind to perlecan, whereas the hybrid does not. Glomerular visceral epithelial cells produced significantly higher amounts of HS than do mesangial cells as revealed by the HS-specific ELISA.
